European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research

Thomas Lehner, Michael Hoelscher, Mario Clerici, Frances Gotch, Louise Pedneault, Jim Tartaglia, Clive Gray, Jiri Mestecky, Quentin Sattentau, Janneke Van De Wijgert, Coumba Toure, Saladin Osmanov, Reinold E. Schmidt, Patrice Debre, Manuel Romaris, Arnd Hoeveler, Simonetta Di Fabio

Research output: Contribution to journalArticlepeer-review

Abstract

The European Commission (EC) has strong commitments and recognises the need to continue to ensure that HIV/AIDS research efforts receive global attention. The EC is facing this challenge in a global context and has made substantial investments together with European Developing Countries Clinical Trial Partnership (EDCTP) to formulate a program for the accomplishment of a scientific strategic plan promoting the European/African HIV vaccine development approach. The EC and EDCTP has convened a number of meetings by experts in basic and clinical virology, immunology, epidemiology, as well as industrial and regulatory representatives. The remit of the committee of experts was to define (1) objective criteria for selection of HIV candidates; (2) to determine criteria for selection of sites for clinical trials in Europe and Africa. The resulting consensus paper will guide the EC and EDCTP in developing HIV vaccine strategy and recommendations.

Original languageEnglish
Pages (from-to)5551-5556
Number of pages6
JournalVaccine
Volume23
Issue number48-49
DOIs
Publication statusPublished - Dec 1 2005

Keywords

  • European Commission Strategy
  • HIV/AIDS
  • Vaccine

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Fingerprint Dive into the research topics of 'European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research'. Together they form a unique fingerprint.

Cite this